GlobalData on MSN
Boston Scientific touts long-term data of SCS therapy
At the recently concluded North American Neuromodulation Society annual meeting, Boston presented a total of 17 abstracts.
Boston Scientific (NYSE:BSX) announced today that it completed its previously announced acquisition of Nalu Medical.
EINDHOVEN, the Netherlands, Jan. 23, 2026 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD – US ADR: ONWRY), the neurotechnology company pioneering spinal cord stimulation therapies to restore ...
ONWARD Medical N.V. (Euronext: ONWD - US ADR: ONWRY), the neurotechnology company pioneering spinal cord stimulation therapies to restore movement ...
Zacks Investment Research on MSN
CLPT gets EU MDR certification for ClearPoint navigation software
ClearPoint Neuro, Inc. CLPT, a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine, recently received EU MDR Certification for its ClearPoint ...
Abbott’s neuromodulation systems can significantly reduce pain-related healthcare visits for people living with chronic pain, according to five-year data.
In a first, this week the U.S. Food and Drug Administration approved a brain stimulation device designed to treat depression at home. The approval of the first such device for home depression ...
News-Medical.Net on MSN
BU receives $2M grant to study MedRhythms' MOVIVE device for Parkinson's gait
Boston University (BU) today announced it has been awarded a $2 million research grant from The Michael J. Fox Foundation for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results